Refer A Patient

Request An Appointment

Pulmonology

FASENRA

FASENRA (benralizumab) is a monoclonal antibody that helps the body’s immune system by reducing the level of a certain type of white blood cells.
Infusion or injection therapy referral
What it treats Severe eosinophilic asthma
Prescribed by Pulmonologists
How it’s administered Subcutaneous injection
Frequency Every four weeks for three doses, and then every eight weeks
Length of treatment About 15 minutes, plus 30-minute observation

About This Therapy

FASENRA (benralizumab) is a monoclonal antibody that helps the body’s immune system by reducing the level of a certain type of white blood cells, helping to protect healthy cells from damage. Specifically, it is an interleukin-5 receptor alpha-directed cytolytic monoclonal antibody (IgG1 kappa) used as an add-on maintenance treatment of patients with severe asthma aged 12 years and older with an eosinophilic phenotype.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

FASENRA REFERRAL FORM

FASENRA REFERRAL FORM

Speak with your healthcare provider to learn if this therapy is right for you, then complete the referral form below.
REFERRAL FORM →

Ready to refer a patient for FASENRA

Our team handles benefits verification, prior authorization, and scheduling so you can focus on care.